Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31566309

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Oct 24
First author
Kopetz S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Dec;16(12):723. doi: 10.1038/s41571-019-0286-1.
    note
    Source null
    related pmid
    31601986
    relationship
    Comment in
  2. citation
    N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101675
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101676
    relationship
    Comment in
  4. citation
    N Engl J Med. 2020 Feb 27;382(9):876-877. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101677
    relationship
    Comment in

Authors and identifiers

  1. name
    Kopetz S
    type
    Author
  2. name
    Grothey A
    type
    Author
  3. name
    Yaeger R
    type
    Author
  4. name
    Van Cutsem E
    type
    Author
  5. name
    Desai J
    type
    Author
  6. name
    Yoshino T
    type
    Author
  7. name
    Wasan H
    type
    Author
  8. name
    Ciardiello F
    type
    Author
  9. name
    Loupakis F
    type
    Author
  10. name
    Hong YS
    type
    Author
  11. name
    Steeghs N
    type
    Author
  12. name
    Guren TK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kopetz S
    type
    Author
  2. name
    Grothey A
    type
    Author
  3. name
    Yaeger R
    type
    Author
  4. name
    Van Cutsem E
    type
    Author
  5. name
    Desai J
    type
    Author
  6. name
    Yoshino T
    type
    Author
  7. name
    Wasan H
    type
    Author
  8. name
    Ciardiello F
    type
    Author
  9. name
    Loupakis F
    type
    Author
  10. name
    Hong YS
    type
    Author
  11. name
    Steeghs N
    type
    Author
  12. name
    Guren TK
    type
    Author
bibliography ids
  1. nci-bib-575c2ccd0286b119b264f21c
book metadata
content sha256
bfec3672b1b88b2586910c38e69bbadb9963043dee3a7ae616aaebc77fcb3039
document type
citation
dois
  1. 10.1056/NEJMoa1908075
electronic publication date
display
2019 Sep 30
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31566309
immutable id
pubmed:31566309@bfec3672b1b88b2586910c38e69bbadb9963043dee3a7ae616aaebc77fcb3039
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
17
name
The New England journal of medicine
nlm unique id
0255562
pages
1632-1643
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Dec;16(12):723. doi: 10.1038/s41571-019-0286-1.
    note
    Source null
    related pmid
    31601986
    relationship
    Comment in
  2. citation
    N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101675
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Feb 27;382(9):876. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101676
    relationship
    Comment in
  4. citation
    N Engl J Med. 2020 Feb 27;382(9):876-877. doi: 10.1056/NEJMc1915676.
    note
    Source null
    related pmid
    32101677
    relationship
    Comment in
outcomes validated
false
pmid
31566309
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
c3de0504a2c103d128919a8ed287a820bc0c3d0b7f02417fe6a278d274bff30e
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Oct 24
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31566309/
title
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice